Rutgers startup Zena Therapeutics strives to create narcotic medications that will minimize or even eliminate overdoses from prescription drugs.
The Clinical and Translational Science Award (CTSA), the state’s only CTSA, transforms research discoveries into practical treatments, and is funded through the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).